StockData
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. (MCRB) stock

MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$1.44+0.03 (+2.13%)

Close on Nov 18, 2026Market cap $14.32MP/E –Yield –

Seres Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Seres Therapeutics's market cap was $14.74M on Nov 11, 2026, against $157.68M a year earlier. Over the last 5 years it ranged from $14.74M to $817.84M, with a median of $153.95M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$14.74M-88.7%
2025Dec 31, 2025$130.42M-7.8%
2024Dec 31, 2024$141.44M-21.5%
2023Dec 29, 2023$180.08M-74.2%
2022Dec 30, 2022$696.70M-8.9%
2021Dec 31, 2021$765.04M-65.8%
2020Dec 31, 2020$2.23B+825.4%
2019Dec 31, 2019$241.48M+30.8%
2018Dec 31, 2018$184.62M-55.1%
2017Dec 29, 2017$410.80M+2.8%
2016Dec 30, 2016$399.52M-70.8%
2015Dec 31, 2015$1.37B–

More Seres Therapeutics figures

See a number that looks wrong?